The influence of switching from haloperidol decanoate depot to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia

Human Psychopharmacology

Volumn 27, Issue 5, 2012, Pages 470-475

  Suzuki, Hidenobu ^a   Gen, Keishi ^b  

^a Tanzawa Hospital   (Japan)

^b Seimo Hospital   (Japan)

Author keywords

attention; executive function; haloperidol decanoate depot; memory; motor processing function; risperidone long acting injection

Indexed keywords

BIPERIDEN; HALOPERIDOL DECANOATE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MEMORY; MONOTHERAPY; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; WISCONSIN CARD SORTING TEST;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; DELAYED-ACTION PREPARATIONS; DIAGNOSIS, COMPUTER-ASSISTED; EXECUTIVE FUNCTION; FEMALE; HALOPERIDOL; HUMANS; INJECTIONS; MALE; MEMORY; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SCHIZOPHRENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866734138     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2249     Document Type: Article

References (20)

1. Cuesta MJ, Peralta V, Zarzuela A,. 2001. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr Res 48: 17-28.
2. Eerdekens M, Van Hove I, Remmerie B, Mannaert E,. 2004. Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia. Schizophr Res 70: 91-100.
3. Heaton RK, Chelune GL, Talley JL, Kay GG, Curtiss G,. 1993. Wisconsin Card Sorting Test Manual: Revised and Expanded. Psychological Assessment Resourses: Oclessa.
4. Inagaki A, Inada T,. 2010. Dose equivalence of psychotropic drugs. Part XXII: dose equivalence of depot antipsychotics III: risperidone long-acting injection. Jpn Clin Psychopharmacol 13: 1349-1353.
5. Kashima H,. 2002. Tests for executive function. Jpn Psychiatry Diagn 13 (2): 205-212.
6. Kay SR, Fiszbein A, Opler LA,. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-276.
7. Kern RS, Green MF, Cornblatt BA, et al,. 2006. The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine. Psychopharmacology (Berl) 187: 312-320.
8. Kim SW, Shin IS, Kim JM, Lee YH, Yang SJ, Yoon JS,. 2009. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia. Hum Psychopharmacol 24 (7): 565-573.
9. Leucht S, Komossa K, Rummel-Kluge C, et al,. 2009a. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry 166: 152-163.
10. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM,. 2009b. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373 (9657): 31-41.
11. McEvoy JP,. 1987. A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function. J Clin Psychiatry 48 (Suppl): 20-23.
12. Meltzer HY, McGurk SR,. 1999. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25: 233-255.
13. Mishara AL, Goldberg TE,. 2004. A meta-analysis and critical review of effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book. Biol Psychiatry 55: 1013-1022.
14. Moller HJ,. 2006. Long-acting risperidone: focus on safety. Clin Ther 28: 633-651.
15. Mori K, Nagano M, Yamashita H, Morinobu S, Yamawaki S,. 2004. Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28: 659-665.
16. Purdon SE, Jones BDW, Stip E, et al,. 2000. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. Arch Gen Psychiatry 57: 249-258.
17. Riedel M, Muller N, Spellmann I, et al,. 2007. Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an active episode of schizophrenia. Eur Arch Psychiatry Clin Neurosci 257 (7): 402-412.
18. Spohn HE, Strauss ME,. 1989. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol 98: 367-380.
19. Suzuki H, Gen K, Inoue Y,. 2011. An unblended comparison of clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, Perospirone or olanzapine in patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 35: 161-168.
20. Suzuki H, Gen K,. 2012. The influence of switching from oral risperidone to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia. Ther Adv Psychopharmacol 2 (1): 23-29.